Market rumors abound that pharmaceutical sales reps at Pfizer may be the next to go. CNBC and Bloomberg are announcing the possibility that 2400 US domestic sales employees (about a third of the sales force) may be let go due to off patent drug expiry, and no doubt the current world financial crisis?
The irony is that we reported about a month ago that Pfizer was ranked number 1 in traditional detailing by physicians.
Pharmaceutical Sales Rep Calls And Sales Force Effectiveness – The Trend
It would not surprising of course to see sales rep layoffs coming in the medical device business as well – judging by the recent news at Cardinal.
Economic Downturn Hits Hospital Supply And Medical Device Business
Related posts:
- Pharmaceutical Sales Rep Calls And Sales Force Effectiveness – The Trend
- Some Sanctimonious And Some Not So Sanctimonious NHS Doctors Writing in the BMJ – British Medical Journal
- International Trading Group
- Bruno Cocheteux Joins Sibaya Lifescience – Heads Up New Pharmaceutical And Medical Device Operations And R&D Practice
- German Health Minister Philipp Roesler – To Slam Pharma – (Wheelchairs And Homecare Next)?
